CAS: 20265-39-8; 2-Methoxypyridin-4-Amine

上下游产品

CAS号14432-12-3 4-氨基-2-氯吡啶 | CAS号124-41-4 甲醇钠 | CAS号14395-39-2 2-甲氧基-4-硝基吡啶 1-氧化物 | CAS号67-56-1 甲醇 | CAS号1628-89-3 2-甲氧基吡啶 | CAS号20773-98-2 6-methoxy-1-oxi... | CAS号88511-26-6 2-碘-4-氨基吡啶 | CAS号33623-16-4 2-甲氧基-3-硝基吡啶-4-胺 | CAS号408502-23-8 2-甲氧基吡啶-4-戊酰硼酸 | CAS号849353-31-7 (2-甲氧基-吡啶-4-基)-... | CAS号96530-75-5 4-氟吡啶-2-酮 | CAS号96530-81-3 2-甲氧基-4-氟吡啶 | CAS号72716-86-0 4-氰基-2-甲氧基砒啶 | CAS号1393563-12-6 3,5-二溴-2-甲氧基吡啶-4-胺 | CAS号100367-39-3 4-溴-2-甲氧基吡啶 | CAS号22282-72-0 2-羟基异烟酸 | CAS号215364-86-6 3-溴-2-甲氧基吡啶-4-胺

2-甲氧基吡啶置于硫酸,硝酸,铁粉,溶剂黄146,间氯过氧苯甲酸体系中,用 二氯甲烷 用作溶剂,化学反应生成4-氨基-2-甲氧基吡啶
参考文献: Nicotinic Receptor Compounds[fr] Composés De Récepteurs Nicotiniques
标题: Nicotinic Receptor Compounds[fr] Composés De Récepteurs Nicotiniques
摘要:本文提供了一些化合物和制备这些化合物的方法,这些化合物能够作为尼古丁受体的激动剂或拮抗剂.还提供了包含这些化合物中的一个或多个的药物组合物,这些组合物可能进一步包含一个或多个额外的治疗剂.此外还提供了治疗各种可能对尼古丁受体活性敏感的疾病的方法,如尼古丁依赖症.

专利信息

专利号:US-9751851-B2
优先权日:2013-09-20
标 题:Molecules and compositions that inhibit gram negative bacteria and their uses
发明人：BASSLER BONNIE L; SEMMELHACK MARTIN F; DRESCHER KNUT; SIRYAPORN ALBERT; CONRAD-MILLER LAURA C; O'LOUGHLIN COLLEEN T
权利人:UNIV PRINCETON; BASSLER BONNIE L; SEMMELHACK MARTIN F; DRESCHER KNUT; SIRYAPORN ALBERT; MILLER LAURA C; O'LOUGHLIN COLLEEN T
摘要:Antivirulence strategies to combat Pseudomonas aeruginosa , are described. One strategy encompasses synthesis of a series of compounds that inhibit the production of pyocyanin, a redox-active virulence factor produced by this pathogen. A related strategy encompasses synthesis of compounds that inhibit the two P. aeruginosa quorum-sensing receptors, LasR and RhlR, inhibit production of pyocyanin, and inhibit biofilm formation.

专利号:EP-3567040-B1
优先权日:2013-06-24
标 题 :Method for the preparation of intermediates useful for the synthesis of [1,2,4]-triazolo[4,3-a]pyridines

专利号:US-10233182-B2
优先权日:2014-04-04
标题 :Substituted spirocyclic inhibitors of autotaxin
发明人：BABISS LEE; CLARK MATTHEW; KEEFE ANTHONY D; MULVIHILL MARK J; NI HAIHONG; RENZETTI LOUIS; RUEBSAM FRANK; WANG CE; XIE ZHIFENG; ZHANG YING
权利人:X RX INC
摘要:The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.

专利号:US-9370515-B2
优先权日:2013-03-07
标题 :Mixed lineage kinase inhibitors and method of treatments
发明人：GOODFELLOW VAL S; NGUYEN THONG X; RAVULA SATHEESH B; GELBARD HARRIS A
权利人:CALIFIA BIO INC; UNIV ROCHESTER
摘要:Provided herein are imidazopyridine compounds having an inhibitory effect on mixed lineage kinases (MLKs), methods of their synthesis, and methods of their therapeutic. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and pharmaceutical compositions.

专利号:EP-3567040-A1
优先权日:2013-06-24
标题 :Method for the preparation of intermediates useful for the synthesis of [1,2,4]-triazolo[4,3-a]pyridines

专利号:US-9957277-B2
优先权日:2015-11-25
标题 :eIF4A-inhibiting compounds and methods related thereto
发明人：ERNST JUSTIN T; REICH SIEGFRIED H; SPRENGELER PAUL A; TRAN CHINH VIET; PACKARD Garrick Kenneth; XIANG ALAN X; NILEWSKI CHRISTIAN; MICHELS THEO
权利人:EFFECTOR THERAPEUTICS INC
摘要:The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. n nFor Formula I compounds X, Y, R 1 , R 2 , R 3a , R 3b , R 4a , R 4b and R 5 are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4A and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.